CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024
CureVac N.V. (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), will report financial results, and provide business updates for the fourth quarter and full-year 2023 on Wednesday, April 24, 2024.
The company will host a conference call and webcast on the same day at 3 p.m. CET / 9 a.m. EST.